ClinicalTrials.gg
Not yet recruitingNCT07735299Updated Jul 29, 2026

Jigsaw Cooperative Learning for Pediatric Pain Education in Undergraduate Nursing Students

An interventional study of Jigsaw cooperative learning and Traditional Lecture-Based Education in Pediatric Pain Education, sponsored by University of Rome Tor Vergata. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by University of Rome Tor Vergata · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
151
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 213 studies in Pain with a site in Italy — 35 open to participants now, 41 under way, 1 of them phase 3. Pain · Italy.

Planned enrollment
41st of 156
151 · median 80
Started
2026
with 7 others
No phase
102 of 213
14 open now
Primary completion
2027-04
later than 33 of 40 live
Registered
212th of 213
by date

Among the 213 studies in Pain with a site in Italy, this one is the 41st largest by planned enrollment of the 156 interventional ones that give a count, is one of 8 that started in 2026, is one of 102 with no phase, reaches primary completion later than 33 of the 40 other live ones, and was the 212th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

35 of the 213 studies in Pain with a site in Italy are open now. Recruiting first, the newest first:

30 more — sign in →

All 35 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 213 studies in Pain with a site in Italy, or all of them as a file.
02

Study summary

Background

Despite growing evidence supporting active learning methodologies in nursing education, limited evidence is available regarding the effectiveness of the Jigsaw cooperative learning technique in improving undergraduate nursing students' competencies in pediatric pain management.

Objective

To evaluate whether the Jigsaw cooperative learning method improves nursing students' knowledge and attitudes regarding pediatric pain management compared with traditional lecture-based education.

Methods

This multicenter, parallel-group randomized controlled trial will be conducted among third-year undergraduate nursing students from the University of Perugia and Unilink University (Italy). Participants will be randomly allocated (1:1) to either a Jigsaw-based educational intervention or traditional lecture-based teaching. Knowledge and attitudes will be assessed using the Italian validated Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) at baseline (T0), immediately after the intervention (T1), and 30 days later (T2). Student satisfaction will also be evaluated using a Visual Analogue Scale (VAS).

Read the detailed description

This multicenter randomized controlled trial aims to evaluate the effectiveness of the Jigsaw cooperative learning technique in undergraduate nursing education.

Participants will be recruited from two Italian universities offering undergraduate nursing programs.

Following written informed consent, eligible participants will complete baseline assessment using the Italian validated Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS).

Participants will then be randomized (1:1), using computer-generated block randomization stratified by study site, to either:

Jigsaw cooperative learning Traditional lecture-based education

Both groups will receive identical educational content concerning pediatric pain management.

The intervention will last two weeks with approximately five hours of structured educational activities.

Outcome assessments will be performed immediately after the intervention (T1) and at 30-day follow-up (T2).

The primary endpoint will be the total PNKAS score immediately after the intervention.

Secondary outcomes include knowledge retention, longitudinal score changes, effect size estimation, and student satisfaction.

03

Conditions studied

  • Pediatric Pain Education

Browse trials for

Keywords

  • Cooperative Learning
  • Jigsaw
  • Nursing Education
  • Pediatric Pain
  • Undergraduate Nursing Students
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Third-year undergraduate nursing student.
  • Attendance of the pediatric nursing course.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Previous advanced education in pediatric pain management.
  • Failure to complete baseline assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
151 participants (estimated)

Study arms

  • Experimental
    Jigsaw Cooperative Learning

    Educational intervention based on the Jigsaw cooperative learning technique.

    Other: Jigsaw cooperative learning

  • Active comparator
    Traditional Lecture-Based Education

    Conventional lecture-based teaching covering identical educational content.

    Other: Traditional Lecture-Based Education

Interventions

  • OtherJigsaw cooperative learning

    Educational intervention based on the Jigsaw cooperative learning technique

  • OtherTraditional Lecture-Based Education

    Conventional lecture-based teaching covering identical educational content

06

What researchers measure

Primary outcomes

  1. Total Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score.

    Total score on the Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS). The PNKAS consists of 42 items with a total score ranging from 0 to 42, where higher scores indicate greater knowledge and more appropriate attitudes toward pediatric pain management.

    Time frame: Immediately after intervention (T1)

Secondary outcomes

  1. Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score change from baseline (T0) to T1

    Change in the total score on the Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) from baseline (T0) to immediately after the intervention (T1). The total score ranges from 0 to 42. Higher scores indicate better knowledge and attitudes regarding pediatric pain management.

    Time frame: Immediately after intervention

  2. Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score at 30-day follow-up

    Total score on the Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) at 30-day follow-up (T2). The total score ranges from 0 to 42. Higher scores indicate better knowledge and attitudes regarding pediatric pain management.

    Time frame: 30 days

  3. Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score change from T1 to T2

    Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score change from T1 to T2

    Time frame: 30 days

  4. Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score change from T0 to T2

    Pediatric Nurses' Knowledge and Attitudes Survey Regarding Pain (PNKAS) score change from T0 to T2

    Time frame: 30 days

  5. Student satisfaction assessed by Visual Analogue Scale (0-10)

    Student satisfaction measured using a 10-cm Visual Analogue Scale (VAS), ranging from 0 to 10, where 0 indicates "not satisfied at all" and 10 indicates "extremely satisfied." Higher scores indicate greater satisfaction with the educational intervention.

    Time frame: Immediately after intervention

07

Study locations

1 site
  • UNIVERSITY OF PERUGIA - Degree Course in Nursing
    Perugia, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 5 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2026
First posted
Jul 29, 2026
StartEst.
Nov 2026
Primary completionEst.
Apr 2027
CompletionEst.
Sep 2027
Last update
Jul 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07735299
Lead sponsor
University of Rome Tor Vergata
Responsible party
Fabrizio Faina (Principal Investigator, University of Rome Tor Vergata) — Principal investigator
First posted
Jul 29, 2026
Start date
Nov 2026 (estimated)
Primary completion
Apr 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Jul 29, 2026

Study contacts

FABRIZIO FAINA, RN, MSN
Contact
fabrizio.faina@gmail.com
+393472651617

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion